Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Croitoru Lamoury, Juliana ^a   Lamoury, Francois M J ^a   Caristo, Michael ^a   Suzuki, Kazuo ^a   Walker, David ^b   Takikawa, Osamu ^c   Taylor, Rosanne ^d   Brew, Bruce J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; RNA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ADULT; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENETICS; MALE; METABOLISM; PHYSIOLOGY;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-BETA; INTERFERON-GAMMA; KYNURENINE; MALE; MESENCHYMAL STEM CELLS; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; RNA;

EID: 79951934032     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014698     Document Type: Article

References (63)

1. Stone TW, (2001) Kynurenines in the CNS: From endogenous obscurity to therapeutic importance. Prog Neurobiol 64: 185-218.
2. Costantino G, (2009) New promises for manipulation of kynurenine pathway in cancer and neurological diseases. Expert Opin Ther Targets 13: 247-258.
3. Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, et al. (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res 67: 7082-7087.
4. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, et al. (2007) Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396: 203-213.
5. Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH, (2009) Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 41: 467-471.
6. Austin CJ, Astelbauer F, Kosim-Satyaputra P, Ball HJ, Willows RD, et al. (2009) Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. Amino Acids 36: 99-106.
7. Lob S, Konigsrainer A, Zieker D, Brucher BL, Rammensee HG, et al. (2009) IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother 58: 153-157.
8. Takikawa O, Tagawa Y, Iwakura Y, Yoshida R, Truscott RJ, (1999) Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice. Adv Exp Med Biol 467: 553-557.
9. Puccetti P, (2007) On watching the watchers: IDO and type I/II IFN. Eur J Immunol 37: 876-879.
10. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
11. Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L, (2009) The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection. J Neurol Sci.
12. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, et al. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29: 202-209.
13. Mellor A, (2005) Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338: 20-24.
14. Moffett JR, Namboodiri MA, (2003) Tryptophan and the immune response. Immunol Cell Biol 81: 247-265.
15. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459-468.
16. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, et al. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9: 1069-1077.
17. Hill M, Tanguy-Royer S, Royer P, Chauveau C, Asghar K, et al. (2007) IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol 37: 3054-3062.
18. Kahler DJ, Mellor AL, (2009) T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase. Handb Exp Pharmacol pp. 165-196.
19. Uccelli A, Moretta L, Pistoia V, (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
20. Matysiak M, Stasiolek M, Orlowski W, Jurewicz A, Janczar S, et al. (2008) Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism. J Neuroimmunol 193: 12-23.
21. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
22. Ryan JM, Barry FP, Murphy JM, Mahon BP, (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8.
23. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, et al. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61: 219-227.
24. Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, et al. (2006) Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198: 275-284.
25. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, et al. (2005) Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436: 266-271.
26. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, et al. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310: 850-855.
27. Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM, (2005) Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105: 1574-1581.
28. Yadav MC, Burudi EM, Alirezaei M, Flynn CC, Watry DD, et al. (2007) IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 55: 1385-1396.
29. Lamoury F, Croitoru-Lamoury J, Brew B, (2006) Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1. Cytotherapy 8: 228-242.
30. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, et al. (2009) Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27: 909-919.
31. Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM, (2007) Interferon: cellular executioner or white knight? Curr Med Chem 14: 1279-1289.
32. Kwidzinski E, Bechmann I, (2007) IDO expression in the brain: A double-edged sword. J Mol Med 85: 1351-1359.
33. Teige I, Treschow A, Teige A, Mattsson R, Navikas V, et al. (2003) IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 170: 4776-4784.
34. Makar TK, Trisler D, Bever CT, Goolsby JE, Sura KT, et al. (2008) Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis. J Neuroimmunol 196: 67-81.
35. Kwidzinski E, Bunse J, Aktas O, Richter D, Mutlu L, et al. (2005) Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. Faseb J 19: 1347-1349.
36. Amirkhani A, Rajda C, Arvidsson B, Bencsik K, Boda K, et al. (2005) Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients. Eur J Neurol 12: 625-631.
37. Tyndall A, Gratwohl A, (2009) Adult stem cell transplantation in autoimmune disease. Curr Opin Hematol 16: 285-291.
38. Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, et al. (2003) Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 24: 623-631.
39. Wong G, Goldshmit Y, Turnley AM, (2004) Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol 187: 171-177.
40. Grohmann U, Bronte V, (2010) Control of immune response by amino acid metabolism. Immunol Rev 236: 243-264.
41. Zelante T, Fallarino F, Bistoni F, Puccetti P, Romani L, (2009) Indoleamine 2,3-dioxygenase in infection: The paradox of an evasive strategy that benefits the host. Microbes Infect 11: 133-141.
42. Orabona C, Grohmann U, (2010) Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond. Methods Mol Biol 677: 269-280.
43. Munn DH, Sharma MD, Mellor AL, (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 172: 4100-4110.
44. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, et al. (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176: 6752-6761.
45. Di Pucchio T, Danese S, De Cristofaro R, Rutella S, (2010) Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. Expert Opin Ther Pat 20: 229-250.
46. Kaper T, Looger LL, Takanaga H, Platten M, Steinman L, et al. (2007) Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. PLoS Biol 5: e257.
47. Travers MT, Gow IF, Barber MC, Thomson J, Shennan DB, (2004) Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Biochim Biophys Acta 1661: 106-112.
48. Kudo Y, Boyd CA, (2001) The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants. J Physiol 531: 417-423.
49. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, et al. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22: 633-642.
50. Lu C, Lin Y, Yeh SR, (2010) Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase. Biochemistry 49: 5028-5034.
51. Lum M, Croze E, Wagner C, McLenachan S, Mitrovic B, et al. (2009) Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is coupled to neuronal differentiation. J Neuroimmunol 206: 32-38.
52. Johansson S, Price J, Modo M, (2008) Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells 26: 2444-2454.
53. Barish ME, Mansdorf NB, Raissdana SS, (1991) Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev Biol 144: 412-423.
54. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM, (2009) The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 113: 2394-2401.
55. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G, (2009) Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 456: 101-106.
56. Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, et al. (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2: 8.
57. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, et al. (2002) Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality. Stem Cells 20: 530-541.
58. Meirelles Lda S, Nardi NB, (2003) Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123: 702-711.
59. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
60. Manuelpillai U, Ligam P, Smythe G, Wallace EM, Hirst J, et al. (2005) Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and with clinical infection. Am J Obstet Gynecol 192: 280-288.
61. Walker DW, Curtis B, Lacey B, Nitsos I, (1999) Kynurenic acid in brain and cerebrospinal fluid of fetal, newborn, and adult sheep and effects of placental embolization. Pediatr Res 45: 820-826.
62. Song S, Zhang H, Cuevas J, Sanchez-Ramos J, (2007) Comparison of neuron-like cells derived from bone marrow stem cells to those differentiated from adult brain neural stem cells. Stem Cells Dev 16: 747-756.
63. Stenderup K, Justesen J, Clausen C, Kassem M, (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.